1. Maternal obesity, gestational diabetes, and central nervous system birth defects;Anderson;Epidemiology,2005
2. Antipsychotics: risk of extrapyramidal effects or withdrawal symptoms in newborns Drug Safety Update - GOV.UK [WWW Document], n.d. URL https://www.gov.uk/drug-safety-update/antipsychotics-risk-of-extrapyramidal-effects-or-withdrawal-symptoms-in-newborns#further-information (accessed 11.14.15).
3. Generalisability of The Health Improvement Network (THIN) database: demographics, chronic disease prevalence and mortality rates;Blak;Inform. Prim. Care,2011
4. Antipsychotics during pregnancy: relation to fetal and maternal metabolic effects;Boden;Arch. Gen. Psychiatry,2012
5. Olanzapine in pregnancy and breastfeeding: a review of data from global safety surveillance;Brunner;BMC Pharmacol. Toxicol.,2013